Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Hold
595
0.04% 89
2026
Q1
$209K Buy
+595
New +$212K 0.05% 86
2024
Q4
Sell
-795
Closed -$256K 78
2024
Q3
$256K Hold
795
0.03% 77
2024
Q2
$248K Sell
795
-300
-27% -$88.1K 0.03% 75
2024
Q1
$311K Sell
1,095
-50
-4% -$14.6K 0.04% 76
2023
Q4
$308K Hold
1,145
0.05% 76
2023
Q3
$308K Hold
1,145
0.05% 76
2023
Q2
$254K Hold
1,145
0.04% 83
2023
Q1
$277K Hold
1,145
0.05% 85
2022
Q4
$301K Buy
1,145
+1,090
+1,982% +$292K 0.07% 72
2022
Q3
$12.4K Sell
55
-827
-94% -$200K ﹤0.01% 142
2022
Q2
$215K Buy
882
+827
+1,504% +$203K 0.06% 78
2022
Q1
$13.3K Buy
+55
New +$12.6K ﹤0.01% 141

Other funds holding AMGN

De Burlo Group's AMGN Position: Q2 2026 in Review

De Burlo Group held its Amgen (AMGN) position steady in Q2 2026 at 595 shares worth $215K. The position accounts for 0.04% of the portfolio, ranked #89.

De Burlo Group first reported a position in AMGN in Q1 2022 and has held it in 13 quarters since. The position peaked at $311K in Q1 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • De Burlo Group held 595 shares of Amgen worth $215K as of Q2 2026.
  • De Burlo Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of De Burlo Group's portfolio in Q2 2026, its #89 holding.
  • De Burlo Group first reported a position in Amgen in Q1 2022 and has held it in 13 quarters since.
  • De Burlo Group's Amgen position peaked at $311K in Q1 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on De Burlo Group's 13F filing for Q2 2026, filed 13 Aug 2026.